Serina Therapeutics to Present at Tribe Public’s Webinar Event "Enabling Continuous Drug Delivery for Parkinson's Disease & Beyond" on Wednesday, December 18, 2024

HUNTSVILLE, AL, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform^™ drug delivery technology, is pleased to announce that Serina’s CEO, Steven A. Ledger will present at Tribe Public’s Webinar Presentation and Q&A Event titled "Enabling Continuous Drug Delivery for Parkinson's Disease & Beyond.” The Event is scheduled to begin at 8:30 am pacific / 11:30 am eastern on Wednesday, December 18, 2024. To register to join the complimentary event, please visit the Tribe Public LLC at SERDEC2024.TribePublic.com.

Read more at globenewswire.com